AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27931249 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally and linguistically tailored web-based sleep educational platform for 2 months
Number of subjects: 200
Study 27931249 — intervention group
Group type: COMPARATOR
Intervention: Standard sleep health literature
Number of subjects: 200
Study 24997476 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dose of 25‐30 minutes of aerobic exercise (STAN)
Number of subjects: 301
Study 24997476 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of 50‐60 minutes of aerobic exercise (HIGH)
Number of subjects: 301
Study 24997476 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of 50‐60 minutes of combined aerobic and resistance exercise (COMB)
Number of subjects: 301
Study 24997476 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall adherence to the supervised exercise sessions
Number of subjects: 301
Study 24997476 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic, medical, fitness, and quality of life predictors
Number of subjects: 301
Study 24997476 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease stage
Number of subjects: 301
Study 24997476 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index
Number of subjects: 301
Study 23077042 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleasant pictures
Number of subjects: 0
Study 23077042 — intervention group
Group type: EXPERIMENTAL
Intervention: Unpleasant pictures
Number of subjects: 0
Study 23077042 — intervention group
Group type: COMPARATOR
Intervention: Neutral pictures
Number of subjects: 0
Study 23077042 — intervention group
Group type: EXPERIMENTAL
Intervention: All picture categories
Number of subjects: 0
Study 20350745 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot gel pads
Number of subjects: 100
Study 20350745 — intervention group
Group type: COMPARATOR
Intervention: No foot gel pads
Number of subjects: 100
Study 18669993 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS) + Treatment as Usual (TAU)
Number of subjects: 41
Study 15746650 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 55
Study 15746650 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 14639098 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine injection (doses not specified)
Number of subjects: 33
Study 14639098 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (0.4 mg)
Number of subjects: 33
Study 14639098 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 33
Study 10888041 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-course radiotherapy alone (Group 1)
Number of subjects: 45
Study 10888041 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy with 6 mg/m2 of cisplatin and split-course radiotherapy (Group 2)
Number of subjects: 45
Study 10888041 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential chemotherapy with two cycles of etoposide, ifosfamide, and cisplatin followed by split-course radiotherapy (Group 3)
Number of subjects: 45
Study 8886466 — intervention group
Group type: EXPERIMENTAL
Intervention: Project TRUST
Number of subjects: 0
Study 8886466 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 1712951 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 28
Study 1712951 — intervention group
Group type: COMPARATOR
Intervention: No antiarrhythmic drug therapy
Number of subjects: 28
Study 31779605 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern contraceptive use
Number of subjects: 632
Study 31779605 — intervention group
Group type: EXPERIMENTAL
Intervention: Family size greater than four
Number of subjects: 632
Study 31779605 — intervention group
Group type: EXPERIMENTAL
Intervention: Family planning counseling service
Number of subjects: 632
Study 31779605 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussing contraceptive issues with sexual partner
Number of subjects: 632
Study 31779605 — intervention group
Group type: EXPERIMENTAL
Intervention: History of giving birth(s)
Number of subjects: 632
Study 31779605 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO clinical stage III or IV
Number of subjects: 632
Study 31779605 — intervention group
Group type: COMPARATOR
Intervention: Older age
Number of subjects: 632
Study 31779605 — intervention group
Group type: COMPARATOR
Intervention: Being widowed
Number of subjects: 632
Study 28685966 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based educational intervention
Number of subjects: 64
Study 28685966 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study 25382448 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrushing + rinsing (0.06% CHX + 0.025% NaF, alcohol-free experimental rinse)
Number of subjects: 155
Study 25382448 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothbrushing + rinsing (0.06% CHX + 0.03% CPC + 0.025% NaF, alcohol-free experimental rinse)
Number of subjects: 155
Study 25382448 — intervention group
Group type: COMPARATOR
Intervention: Toothbrushing + rinsing (0.06% CHX + 0.025% NaF, alcohol-containing rinse, positive control)
Number of subjects: 155
Study 25382448 — intervention group
Group type: COMPARATOR
Intervention: Toothbrushing alone (negative control)
Number of subjects: 155
Study 25382448 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 155
Study 23720950 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 0
Study 21890226 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic plus resistance training (ART)
Number of subjects: 47
Study 21890226 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training (AT)
Number of subjects: 47
Study 20011881 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA) 24 g in 250 ml saline solution
Number of subjects: 53
Study 20011881 — intervention group
Group type: COMPARATOR
Intervention: Placebo (250 ml saline solution)
Number of subjects: 53
Study 20011881 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA)
Number of subjects: 53
Study 20011881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 17501866 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary repair (augmented or non-augmented)
Number of subjects: 100
Study 17501866 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment
Number of subjects: 100
Study 17501866 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ACL repair or reconstruction
Number of subjects: 100
Study 15141917 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group received verbal instructions on phoneme production and used a tongue blade for lingual awareness
Number of subjects: 40
Study 15141917 — intervention group
Group type: COMPARATOR
Intervention: Control group received instructions in articulatory placement only
Number of subjects: 40
Study 11604268 — intervention group
Group type: EXPERIMENTAL
Intervention: Citric acid added to enteric-coated matrix granules and tablet matrix
Number of subjects: 0
Study 11604268 — intervention group
Group type: COMPARATOR
Intervention: Control (without citric acid)
Number of subjects: 0
Study 9819787 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated estrogen (Premarin) 0.625 mg/day orally plus medroxyprogesterone acetate (Farlutal) 10 mg/day orally (RHRT group)
Number of subjects: 55
Study 9819787 — intervention group
Group type: EXPERIMENTAL
Intervention: No medication (NRHRT group)
Number of subjects: 55
Study 9819787 — intervention group
Group type: EXPERIMENTAL
Intervention: NRHRT and RHRT groups
Number of subjects: 55
Study 9819787 — intervention group
Group type: COMPARATOR
Intervention: Premenopausal healthy subjects (PreM group)
Number of subjects: 55
Study 7650533 — intervention group
Group type: EXPERIMENTAL
Intervention: Type II fiber atrophy
Number of subjects: 100
Study 7650533 — intervention group
Group type: EXPERIMENTAL
Intervention: Skeletal myopathy
Number of subjects: 100
Study 7650533 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic cardiomyopathy
Number of subjects: 100
Study 7650533 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral neuropathy
Number of subjects: 100
Study 7650533 — intervention group
Group type: EXPERIMENTAL
Intervention: Cirrhosis
Number of subjects: 100
Study 7650533 — intervention group
Group type: EXPERIMENTAL
Intervention: Total lifetime dose of ethanol
Number of subjects: 100
Study 7650533 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of ideal body weight and lean body mass
Number of subjects: 100
Study 7650533 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric malnutrition
Number of subjects: 100
Study 2523660 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral isradipine
Number of subjects: 9
Study 2523660 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine treatment over 12 weeks
Number of subjects: 9
Study 848803 — intervention group
Group type: EXPERIMENTAL
Intervention: Ragweed inhalation challenge
Number of subjects: 26
Study 848803 — intervention group
Group type: COMPARATOR
Intervention: Mecholyl bronchospastic response
Number of subjects: 26
Study 848803 — intervention group
Group type: COMPARATOR
Intervention: Negative ragweed challenge
Number of subjects: 26
Study 31808584 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 66
Study 31808584 — intervention group
Group type: COMPARATOR
Intervention: Fluoride varnish (FV)
Number of subjects: 66
Study 31808584 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of LLLT and fluoride varnish (L + FV)
Number of subjects: 66
Study 31377287 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-Stent implantation plus phacoemulsification
Number of subjects: 282
Study 31377287 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification alone (Control)
Number of subjects: 282
Study 31377287 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-Stent group
Number of subjects: 282
Study 31377287 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 282
Study 29077812 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple juice
Number of subjects: 48
Study 29077812 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% milk
Number of subjects: 48
Study 29077812 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensure Clear
Number of subjects: 48
Study 24832696 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-pin fixation
Number of subjects: 62
Study 24832696 — intervention group
Group type: COMPARATOR
Intervention: Metal interference screw fixation
Number of subjects: 62
Study 23194841 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense counseling (nutrition education materials included)
Number of subjects: 89
Study 23194841 — intervention group
Group type: COMPARATOR
Intervention: Normal counseling (individualized dietary program)
Number of subjects: 89
Study 23194841 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense counseling
Number of subjects: 89
Study 23194841 — intervention group
Group type: COMPARATOR
Intervention: Normal counseling
Number of subjects: 89
Study 21252704 — intervention group
Group type: EXPERIMENTAL
Intervention: Deeper anesthesia (n = 50)
Number of subjects: 96
Study 21252704 — intervention group
Group type: COMPARATOR
Intervention: Lighter anesthesia (n = 46)
Number of subjects: 96
Study 17611792 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin and docetaxel (AD)
Number of subjects: 210
Study 17611792 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin and paclitaxel (AP)
Number of subjects: 210
Study 17611792 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin and taxane combinations (both arms)
Number of subjects: 210
Study 16830018 — intervention group
Group type: COMPARATOR
Intervention: Propofol 1% alone (Control group)
Number of subjects: 200
Study 16830018 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1% premixed with 40 mg of lidocaine
Number of subjects: 200
Study 16830018 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1% given 60 seconds after 40 mg of lidocaine
Number of subjects: 200
Study 16830018 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous occlusion for 60 seconds with lidocaine 1% (40 mg) followed by propofol
Number of subjects: 200
Study 15477438 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 microg
Number of subjects: 1262
Study 15477438 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 40 microg
Number of subjects: 1262
Study 15477438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1262
Study 15477438 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 1262
Study 11049104 — intervention group
Group type: EXPERIMENTAL
Intervention: TCV-309
Number of subjects: 98
Study 11049104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 9350846 — intervention group
Group type: EXPERIMENTAL
Intervention: NO-GO condition
Number of subjects: 10
Study 9350846 — intervention group
Group type: COMPARATOR
Intervention: GO condition
Number of subjects: 10
Study 7901024 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenspiride hydrochloride (80 mg) administered IV
Number of subjects: 12
Study 7901024 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenspiride hydrochloride (80 mg) administered orally
Number of subjects: 12
Study 7901024 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenspiride hydrochloride (IV and oral)
Number of subjects: 12
Study 3535976 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupenthixol
Number of subjects: 11
Study 3535976 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 29406835 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonthrust manipulation (NTM)
Number of subjects: 103
Study 26895001 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumescent lidocaine without liposuction at a dosage of 28 mg/kg
Number of subjects: 14
Study 26895001 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumescent lidocaine with liposuction at a dosage of 45 mg/kg
Number of subjects: 14
Study 24889008 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral/educational intervention
Number of subjects: 300
Study 23613810 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Dopa
Number of subjects: 50
Study 23613810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 23613810 — intervention group
Group type: EXPERIMENTAL
Intervention: DRD2/ANKK1 genotype
Number of subjects: 50
Study 19939354 — intervention group
Group type: EXPERIMENTAL
Intervention: Low cost micro-camera
Number of subjects: 48
Study 19939354 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional laparoscopic camera
Number of subjects: 48
Study 19939354 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained groups (both cameras)
Number of subjects: 48
Study 19939354 — intervention group
Group type: COMPARATOR
Intervention: Non-trained groups
Number of subjects: 48
Study 19939354 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgeons
Number of subjects: 48
Study 19939354 — intervention group
Group type: COMPARATOR
Intervention: Students
Number of subjects: 48
Study 19014156 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless immediately loaded implants
Number of subjects: 40
Study 19014156 — intervention group
Group type: COMPARATOR
Intervention: Conventional implants (submerged or unsubmerged)
Number of subjects: 40
Study 16898534 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CsA)
Number of subjects: 16
Study 16898534 — intervention group
Group type: COMPARATOR
Intervention: Control group (13 age- and sex-matched individuals)
Number of subjects: 16
Study 12683470 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone (300-600 mg per day in two divided doses)
Number of subjects: 484
Study 12683470 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy (16-20 sessions of CBASP)
Number of subjects: 484
Study 12683470 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nefazodone and psychotherapy
Number of subjects: 484
Study 12683470 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefazodone (alone or in combination with CBASP)
Number of subjects: 484
Study 12683470 — intervention group
Group type: COMPARATOR
Intervention: Nefazodone
Number of subjects: 484
Study 11081319 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril therapy
Number of subjects: 93
Study 11081319 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study 9592270 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluma dentin bonding (experimental group)
Number of subjects: 19
Study 9592270 — intervention group
Group type: COMPARATOR
Intervention: Durafill bonding (control group)
Number of subjects: 19
Study 1532672 — intervention group
Group type: EXPERIMENTAL
Intervention: FUDR (0.05 to 1.7 mg/kg/d) alone or combined with 5-FU and leucovorin
Number of subjects: 221
Study 1532672 — intervention group
Group type: EXPERIMENTAL
Intervention: FUDR, 5-FU, and leucovorin
Number of subjects: 221
Study 1532672 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intraarterial treatment with LCV
Number of subjects: 221
Study 1532672 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional treatment
Number of subjects: 221
Study 2992278 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol transdermal system, 0.1 mg/day
Number of subjects: 124
Study 2992278 — intervention group
Group type: COMPARATOR
Intervention: Conjugated equine estrogens, 0.625 mg/day
Number of subjects: 124
Study 2992278 — intervention group
Group type: COMPARATOR
Intervention: Conjugated equine estrogens, 1.25 mg/day
Number of subjects: 124
Study 31373648 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab plus S‐1 and oxaliplatin
Number of subjects: 189
Study 31373648 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus S‐1 and oxaliplatin
Number of subjects: 189
Study 27666380 — intervention group
Group type: EXPERIMENTAL
Intervention: nuts, seeds, fruit, and fish dietary pattern
Number of subjects: 328
Study 26725556 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg/day)
Number of subjects: 26
Study 26725556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 23830709 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy (SMT) targeted to the C5‐C6 spinal segment
Number of subjects: 33
Study 23830709 — intervention group
Group type: COMPARATOR
Intervention: Sham spinal manipulative therapy
Number of subjects: 33
Study 21830515 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ms display delay
Number of subjects: 0
Study 21830515 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral vision occluded
Number of subjects: 0
Study 21830515 — intervention group
Group type: EXPERIMENTAL
Intervention: Image scale factor
Number of subjects: 0
Study 21830515 — intervention group
Group type: EXPERIMENTAL
Intervention: Delay
Number of subjects: 0
Study 19285849 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouth taping at night
Number of subjects: 51
Study 19285849 — intervention group
Group type: COMPARATOR
Intervention: Usual breathing at night
Number of subjects: 51
Study 16708309 — intervention group
Group type: EXPERIMENTAL
Intervention: Full intervention (communication training)
Number of subjects: 837
Study 16708309 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited intervention (evidence-based guidelines only)
Number of subjects: 837
Study 16708309 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 837
Study 15641877 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 86
Study 15641877 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 86
Study 15641877 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 86
Study 12221393 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX) gel
Number of subjects: 98
Study 12221393 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine (CHX) solution
Number of subjects: 98
Study 12221393 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% CHX solution + a 25% CHX‐containing controlled‐release device
Number of subjects: 98
Study 12221393 — intervention group
Group type: COMPARATOR
Intervention: Ca(OH)(2)
Number of subjects: 98
Study 12221393 — intervention group
Group type: COMPARATOR
Intervention: Ca(OH)(2)+ 0.2% CHX gel
Number of subjects: 98
Study 12221393 — intervention group
Group type: COMPARATOR
Intervention: 0.2% CHX gel
Number of subjects: 98
Study 12221393 — intervention group
Group type: COMPARATOR
Intervention: saline
Number of subjects: 98
Study 12221393 — intervention group
Group type: COMPARATOR
Intervention: gel vehicle
Number of subjects: 98
Study 9891196 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukocyte-interferon-alpha, 6 MU three times a week for 4 months, followed by 3 MU three times a week for 8 months (Group I)
Number of subjects: 107
Study 9891196 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant-IFN-alpha-2a, with the same schedule (Group II)
Number of subjects: 107
Study 9891196 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphoblastoid-IFN-alpha-N1, with the same schedule (Group III)
Number of subjects: 107
Study 7976413 — intervention group
Group type: EXPERIMENTAL
Intervention: Metyrapone (11 beta‐hydroxylase inhibitor) followed by growth hormone releasing hormone (1 microgram kg‐1 body wt)
Number of subjects: 6
Study 7976413 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by growth hormone releasing hormone (1 microgram kg‐1 body wt)
Number of subjects: 6
Study 3076139 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil
Number of subjects: 0
Study 31385741 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-party assessment of complications
Number of subjects: 429
Study 31385741 — intervention group
Group type: COMPARATOR
Intervention: Primary registration in the Swedish Cystectomy Registry
Number of subjects: 429
Study 31385741 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-party assessment
Number of subjects: 429
Study 31385741 — intervention group
Group type: COMPARATOR
Intervention: Primary registration
Number of subjects: 429
Study 29095263 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine (0.5 mL/kg/h, 5 mg/50 mL)
Number of subjects: 60
Study 29095263 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 60